Abstract
Obesity is an important public health problem that may influence the outcomes of hematopoietic cell transplantation (HCT). We studied 898 children and adults receiving first-time allogeneic hematopoietic SCTs between 2004 and 2012. Pretransplant body mass index (BMI) was classified as underweight, normal weight, overweight or obese using the WHO classification or age-adjusted BMI percentiles for children. The study population was predominantly Caucasian, and the median age was 51 years (5 months–73 years). The cumulative 3-year incidence of nonrelapse mortality (NRM) in underweight, normal weight, overweight and obese patients was 20%, 19%, 20% and 33%, respectively. Major causes of NRM were acute and chronic GVHD. The corresponding incidence of relapse was 30%, 41%, 37% and 30%, respectively. Three-year OS was 59%, 48%, 47% and 43%, respectively. Multivariate analysis showed that obesity was associated with higher NRM (hazard ratio (HR) 1.43, P=0.04) and lower relapse (HR 0.65, P=0.002). Pretransplant plasma levels of ST2 and TNFR1 biomarkers were significantly higher in obese compared with normal weight patients (P=0.04 and P=0.05, respectively). The increase in NRM observed in obese patients was partially offset by a lower incidence of relapse with no difference in OS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ulijaszek SJ, Lofink H . Obesity in biocultural perspective. Annu Rev Anthropol 2006; 35: 337–360.
Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012; 10: 22.
Flegal KM, Kit BK, Orpana H, Graubard BI . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71–82.
Juraschek SP, Miller ER 3rd, Gelber AC . Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res (Hoboken) 2013; 65: 127–132.
Wu CY, Chou YC, Huang N, Chou YJ, Hu HY, Li CP . Association of body mass index with all-cause and cardiovascular disease mortality in the elderly. PLoS ONE 2014; 9: e102589.
Population-based approaches to childhood obesity prevention. http://www.who.int/dietphysicalactivity/childhood/WHO_new_childhoodobesity_PREVENTION_27nov_HR_PRINT_OK.pdf (accessed 23 July 2014).
WHO factsheet: obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 23 July 2014).
Solomon CG, Manson JE . Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997; 66: 1044S–1050SS.
Sorror ML, Martin PJ, Storb R, Bhatia S, Maziarz RT, Pulsipher MA et al. Pre-transplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood 2014; 124: 287–295.
Sorror ML . How I assess comorbidities before hematopoietic cell transplantation. Blood 2013; 121: 2854–2863.
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.
Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K et al. Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Blood 2014; 123: 3504–3511.
Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V et al. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant 2011; 17: 737–744.
Bulley S, Gassas A, Dupuis LL, Aplenc R, Beyene J, Greenberg ML et al. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol 2008; 140: 214–217.
Fleming DR, Rayens MK, Garrison J . Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study. Am J Med 1997; 102: 265–268.
Fuji S, Kim SW, Yoshimura K, Akiyama H, Okamoto S, Sao H et al. Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15: 73–82.
Hadjibabaie M, Tabeefar H, Alimoghaddam K, Iravani M, Eslami K, Honarmand H et al. The relationship between body mass index and outcomes in leukemic patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Transplant 2012; 26: 149–155.
Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962–968.
Le Blanc K, Ringden O, Remberger M . A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 2003; 88: 1044–1052.
Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H et al. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant 2010; 16: 1442–1450.
Pine M, Wang L, Harrell FE Jr., Calder C, Manes B, Evans M et al. The effect of obesity on outcome of unrelated cord blood transplant in children with malignant diseases. Bone Marrow Transplant 2011; 46: 1309–1313.
Sucak GT, Suyani E, Baysal NA, Altindal S, Cakar MK, Aki SZ et al. The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning. Int J Hematol 2012; 95: 95–101.
Nikolousis E, Nagra S, Paneesha S, Delgado J, Holder K, Bratby L et al. Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Ann Hematol 2010; 89: 1141–1145.
Nakao M, Chihara D, Niimi A, Ueda R, Tanaka H, Morishima Y et al. Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis. Bone Marrow Transplant 2014; 49: 66–72.
Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, Mineishi S et al. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood 2008; 112: 1539–1542.
Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R et al. A biomarker panel for acute graft-versus-host disease. Blood 2009; 113: 273–278.
Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013; 369: 529–539.
Garrow JS, Webster J . Quetelet's index (W/H2) as a measure of fatness. Int J Obes 1985; 9: 147–153.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii 1–253.
Ogden CL, Flegal KM, Carroll MD, Johnson CL . Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728–1732.
Hanauer DA . EMERSE: The Electronic Medical Record Search Engine. AMIA Annu Symp Proc 2006; 2006: 941.
Osuchowski MF, Siddiqui J, Copeland S, Remick DG . Sequential ELISA to profile multiple cytokines from small volumes. J Immunol Methods 2005; 302: 172–181.
Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496–509.
Gray RJ . A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. Ann Stat 1988; 16: 1141–1154.
Kaplan EL, Meier P . Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628–1633.
Hossain P, Kawar B, El Nahas M . Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 2007; 356: 213–215.
Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012; 42: 563–570.
Prevalence of self-reported obesity among U.S. adults, BRFSS, 2012. http://www.cdc.gov/obesity/data/adult.html#Prevalence (accessed 23 July 2014).
Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr., Reyes JD et al. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009; 15: 968–977.
Heymsfield SB, Cefalu WT . Does body mass index adequately convey a patient's mortality risk? JAMA 2013; 309: 87–88.
Blouin RA, Warren GW . Pharmacokinetic considerations in obesity. J Pharm Sci 1999; 88: 1–7.
Choi S, Reddy P . Graft-versus-host disease. Panminerva Med 2010; 52: 111–124.
Nikolopoulou A, Kadoglou NP . Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther 2012; 10: 933–939.
Zeyda M, Wernly B, Demyanets S, Kaun C, Hammerle M, Hantusch B et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond) 2013; 37: 658–665.
Martinez-Martinez E, Miana M, Jurado-Lopez R, Rousseau E, Rossignol P, Zannad F et al. A role for soluble ST2 in vascular remodeling associated with obesity in rats. PLoS ONE 2013; 8: e79176.
Vazquez LA, Pazos F, Berrazueta JR, Fernandez-Escalante C, Garcia-Unzueta MT, Freijanes J et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90: 316–322.
Miller GD, Nicklas BJ, Loeser RF . Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc 2008; 56: 644–651.
Acknowledgements
We are grateful to the patients, their families and the clinical personnel who participated in this study. We thank the BMT Program Team at the Clinical Trials Office at the University of Michigan for data collection and management. MG was supported by the Student Biomedical Research Program at the University of Michigan Medical School, funded by a training grant from the National Institutes of Health to Dr Benjamin L Margolis (T35HL007690). This study was supported by a grant to SWC from the National Institutes of Health (1K23AI091623). SWC is an A Alfred Taubman Institute/Edith Briskin/SKS Foundation Emerging Scholar.
Author Contributions
MG collected and analyzed the data and drafted and approved the manuscript; YL analyzed the data and approved the manuscript; LC collected and analyzed the data and approved the manuscript; SP conducted scientific analyses and approved the manuscript; DAH collected the data and approved the manuscript; DGF collected and analyzed the data and approved the manuscript; CAB cared for patients and approved the manuscript; PRR designed the study, cared for patients and approved the manuscript; TMB designed the study, analyzed the data and approved the manuscript; SWC designed the study, cared for patients, collected and analyzed the data and drafted and approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Gleimer, M., Li, Y., Chang, L. et al. Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. Bone Marrow Transplant 50, 402–410 (2015). https://doi.org/10.1038/bmt.2014.280
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.280
This article is cited by
-
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
Bone Marrow Transplantation (2023)
-
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
Bone Marrow Transplantation (2022)
-
Abnormal body composition related to the early clinical adverse outcome after HSCT
Bone Marrow Transplantation (2022)
-
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Annals of Hematology (2022)
-
Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables
Bone Marrow Transplantation (2019)